Shots: Given the high variability and subjectivity of traditional clinical scales, there is an urgent need for objective biomarkers to assess CNS disease progression more reliably NeuraLight is at the forefront of precision neurology, developing objective and sensitive biomarkers that bring greater accuracy and consistency to CNS research In this exclusive conversation, Edmund…
Shots: Nearly half of FDA-approved AI medical devices lack testing on real patient data, raising significant concerns about patient safety. PharmaShots welcomes Jay Anders, CMO of Medicomp Systems, to discuss AI implementation trends in healthcare and strategies for ethical AI adoption by healthcare professionals. Jay emphasizes the importance of clinical validations to ensure the safe…

